Clinical Research Site

San Antonio, Texas 78240

6 studies enrolling now · 20 studies all time

What they study most

ADHD, Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation,Psychomotor, Alzheimer Disease, Binge-Eating Disorder, Cataplexy, Chronic Obstructive Pulmonary Disease, Depression, Essential Hypertension, Excessive Daytime Sleepiness, Excessive Sleepiness

Studies at this site

• Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants — Completed
• A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia — Stopped early
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed
• Study in Subjects Greater Than 40 Years of Age With COPD — Completed
• A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism — Completed
• Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis — Completed